New designs for cancer vaccine and artificial veto cells: an emerging palette of protein paints (Q35176440)

6 August 2017

1 reference

title

New designs for cancer vaccine and artificial veto cells: an emerging palette of protein paints (English)

1 reference

6 August 2017

Mark L Tykocinski

1

1 reference

6 August 2017

Aoshuang Chen

2

1 reference

6 August 2017

Jui-Han Huang

3

1 reference

6 August 2017

Matthew C Weber

4

1 reference

6 August 2017

Guoxing Zheng

5

1 reference

6 August 2017

publication date

1 January 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

27

1 reference

6 August 2017

issue

2-3

1 reference

6 August 2017

page(s)

565-574

1 reference

Antigen-presenting cell types

6 August 2017

cites work

1 reference

12 December 2020

Actively acquired tolerance of foreign cells

1 reference

12 December 2020

Antigen-presenting cell engineering. The molecular toolbox

1 reference

12 December 2020

Single cell analysis reveals regulated hierarchical T cell antigen receptor signaling thresholds and intraclonal heterogeneity for individual cytokine responses of CD4+ T cells

1 reference

12 December 2020

Costimulatory regulation of T cell function.

1 reference

12 December 2020

Local administration of dendritic cells inhibits established breast tumor growth: implications for apoptosis-inducing agents

1 reference

12 December 2020

Negative signaling by anti-HLA class I antibodies is dependent upon two triggering events

1 reference

12 December 2020

Reduction of the in vitro cytotoxic lymphocyte response produced by in vivo exposure to semiallogeneic cells: recruitment or active suppression?

1 reference

12 December 2020

Glycosylphosphatidylinositol-modified murine B7-1 and B7-2 retain costimulator function

1 reference

12 December 2020

The use of palmitate-conjugated protein A for coating cells with artificial receptors which facilitate intercellular interactions

1 reference

12 December 2020

Suppression of experimental autoimmune thyroiditis in guinea pigs by pretreatment with thyroglobulin-coupled spleen cells

1 reference

12 December 2020

A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis

1 reference

12 December 2020

Hybrid antibody mediated veto of cytotoxic T lymphocyte responses

1 reference

12 December 2020

Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins

1 reference

12 December 2020

Induction of antigen-specific immunosuppression by CD95L cDNA-transfected 'killer' dendritic cells

1 reference

12 December 2020

Signal for attachment of a phospholipid membrane anchor in decay accelerating factor

1 reference

12 December 2020

Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival

1 reference

12 December 2020

A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions.

1 reference

12 December 2020

Alloantigenic recognition of artificial glycosyl phosphatidylinositol-anchored HLA-A2.1.

1 reference

12 December 2020

Protein transfer of glycosyl-phosphatidylinositol (GPI)-modified murine B7-1 and B7-2 costimulators

1 reference

12 December 2020

Anti-Third Party CD8+ CTLs as Potent Veto Cells

1 reference

12 December 2020

Functional consequences of anti-sense RNA-mediated inhibition of CD8 surface expression in a human T cell clone

1 reference

12 December 2020

Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg

1 reference

12 December 2020

Programmed Cell Death of T Cells Signaled by the T Cell Receptor and the α 3 Domain of Class I MH

1 reference

12 December 2020

Hierarchical costimulator thresholds for distinct immune responses: application of a novel two-step Fc fusion protein transfer method

1 reference

12 December 2020

An immunological suppressor cell inactivating cytotoxic T-lymphocyte precursor cells recognizing it

1 reference

12 December 2020

Role of infused CD8+ cells in the induction of peripheral tolerance

1 reference

12 December 2020

A rheostatic mechanism for T-cell inhibition based on elevation of activation thresholds

1 reference

12 December 2020

An essential role for Fas ligand in transplantation tolerance induced by donor bone marrow.

1 reference

12 December 2020

Induction of specific T cell tolerance by Fas ligand-expressing antigen-presenting cells

1 reference

12 December 2020

Specific immunotherapy by genetically engineered APCs: the "guided missile" strategy

1 reference

12 December 2020

Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts

1 reference

12 December 2020

Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes

1 reference

12 December 2020

Engrafting costimulator molecules onto tumor cell surfaces with chelator lipids: a potentially convenient approach in cancer vaccine development

1 reference

12 December 2020

Construction, purification, and functional incorporation on tumor cells of glycolipid-anchored human B7-1 (CD80).

1 reference

12 December 2020

Glycolipid reanchoring of T-lymphocyte surface antigen CD8 using the 3' end sequence of decay-accelerating factor's mRNA

1 reference

12 December 2020

A reassessment of the role of B7-1 expression in tumor rejection.

1 reference

12 December 2020

CTLA-4-Fas ligand functions as a trans signal converter protein in bridging antigen-presenting cells and T cells

1 reference

12 December 2020

Why so many coinhibitory receptors?

1 reference

12 December 2020

Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein

1 reference

12 December 2020

The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function

1 reference

12 December 2020

Cloned cytolytic T cells can suppress primary cytotoxic responses directed against them

1 reference

12 December 2020

Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation

1 reference

12 December 2020

Generation of primary tumor-specific cytotoxic T lymphocytes from autologous and human lymphocyte antigen class I-matched allogeneic peripheral blood lymphocytes by B7 gene-modified melanoma cells

1 reference

12 December 2020

Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy

1 reference

12 December 2020

Glycosyl-phosphatidylinositol reanchoring unmasks distinct antigen-presenting pathways for CD1b and CD1c

1 reference

12 December 2020

Differential T cell costimulatory requirements in CD28-deficient mice

1 reference

12 December 2020

Targeting of lymphotoxin-alpha to the tumor elicits an efficient immune response associated with induction of peripheral lymphoid-like tissue

1 reference

12 December 2020

T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo

1 reference

12 December 2020

Quantitative studies on the mixed lymphocyte interaction in rats. V. Tempo and specificity of the proliferative response and the number of reactive cells from immunized donors

1 reference

12 December 2020

Construction and characterization of bispecific costimulatory molecules containing a minimized CD86 (B7-2) domain and single-chain antibody fragments for tumor targeting

1 reference

12 December 2020

T cell activation determined by T cell receptor number and tunable thresholds.

1 reference

12 December 2020

Expression of T Cell Antigen Receptor Heterodimers in a Lipid-Linked Form

1 reference

12 December 2020

Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement

1 reference

12 December 2020

Phase I study of direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7, in patients with metastatic melanoma

1 reference

12 December 2020

Efficient direct priming of tumor-specific cytotoxic T lymphocyte in vivo by an engineered APC.

1 reference

12 December 2020

Recombinant anti-human HER2/neu IgG3-(GM-CSF) fusion protein retains antigen specificity and cytokine function and demonstrates antitumor activity

1 reference

12 December 2020

Functional clonal deletion of class I-specific cytotoxic T lymphocytes by veto cells that express antigen

1 reference

12 December 2020

Protein transfer of preformed MHC-peptide complexes sensitizes target cells to T cell cytolysis

1 reference

12 December 2020

Fusion proteins of B7.1 and a carcinoembryonic antigen (CEA)-specific antibody fragment opsonize CEA-expressing tumor cells and coactivate T-cell immunity

1 reference

12 December 2020

4-1BBL cooperates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long-lasting antitumor vaccine

1 reference

12 December 2020

Induction and reversal of long-lived specific unresponsiveness to a T-dependent antigen following CTLA4Ig treatment

1 reference

12 December 2020

A triad of costimulatory molecules synergize to amplify T-cell activation

1 reference

12 December 2020

Prospects for anti-rejection therapies based upon CD8-dependent immunoregulation

1 reference

12 December 2020

Involvement of B lymphocytes in the growth inhibition of human pulmonary melanoma metastases in athymic nu/nu mice by an antibody-lymphotoxin fusion protein

1 reference

12 December 2020

Protein transfer of glycosyl-phosphatidylinositol-B7-1 into tumor cell membranes: a novel approach to tumor immunotherapy

1 reference

12 December 2020

Adenoviral transduction of melanoma cells with B7-1: antitumor immunity and immunosuppressive factors

1 reference

12 December 2020

Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma Cells

1 reference

12 December 2020

A recombinant antibody-interleukin 2 fusion protein suppresses growth of hepatic human neuroblastoma metastases in severe combined immunodeficiency mice

1 reference

12 December 2020

CD8 functions as an inhibitory ligand in mediating the immunoregulatory activity of CD8+ cells

1 reference

12 December 2020

Induction of unresponsiveness and impaired T cell expansion by staphylococcal enterotoxin B in CD28-deficient mice

1 reference

12 December 2020

An immunoregulatory function for the CD8 molecule

1 reference

12 December 2020

Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

1 reference

12 December 2020

Regulation of allogeneic responses by expression of CD8 alpha chain on stimulator cells

1 reference

12 December 2020

Induction of antitumor immunity via intratumoral tetra-costimulator protein transfer

1 reference

12 December 2020

Identifiers

DOI

10.1385/IR:27:2-3:565

1 reference

Dimensions Publication ID

6 August 2017

1049018626

0 references

1 reference